Brazilian antitrust watchdog CADE has blocked a deal announced by healthcare company Hapvida Participações to by health insurer Plamed.
CADE´s technical body had given an earlier approval to the deal demanding the sale of part of its 26,000 clients portfolio, but the councillors voted to bar the deal completely. In a securities filing late on Wednesday, the company said it was discussing with its advisors the alternatives for the deal.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
